JP2009538336A5 - - Google Patents

Download PDF

Info

Publication number
JP2009538336A5
JP2009538336A5 JP2009512260A JP2009512260A JP2009538336A5 JP 2009538336 A5 JP2009538336 A5 JP 2009538336A5 JP 2009512260 A JP2009512260 A JP 2009512260A JP 2009512260 A JP2009512260 A JP 2009512260A JP 2009538336 A5 JP2009538336 A5 JP 2009538336A5
Authority
JP
Japan
Prior art keywords
group
substituted
unsubstituted
compound
glucosidase
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2009512260A
Other languages
English (en)
Japanese (ja)
Other versions
JP5241709B2 (ja
JP2009538336A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2007/069448 external-priority patent/WO2007140184A2/en
Publication of JP2009538336A publication Critical patent/JP2009538336A/ja
Publication of JP2009538336A5 publication Critical patent/JP2009538336A5/ja
Application granted granted Critical
Publication of JP5241709B2 publication Critical patent/JP5241709B2/ja
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2009512260A 2006-05-24 2007-05-22 デオキシノジリマイシンおよびd−アラビニトールのアナログおよび使用方法 Expired - Fee Related JP5241709B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US80277606P 2006-05-24 2006-05-24
US60/802,776 2006-05-24
PCT/US2007/069448 WO2007140184A2 (en) 2006-05-24 2007-05-22 Deoxynojirimycin and d-arabinitol analogs and methods of using

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2013039548A Division JP2013129662A (ja) 2006-05-24 2013-02-28 デオキシノジリマイシンおよびd−アラビニトールのアナログおよび使用方法

Publications (3)

Publication Number Publication Date
JP2009538336A JP2009538336A (ja) 2009-11-05
JP2009538336A5 true JP2009538336A5 (https=) 2010-07-01
JP5241709B2 JP5241709B2 (ja) 2013-07-17

Family

ID=38779322

Family Applications (2)

Application Number Title Priority Date Filing Date
JP2009512260A Expired - Fee Related JP5241709B2 (ja) 2006-05-24 2007-05-22 デオキシノジリマイシンおよびd−アラビニトールのアナログおよび使用方法
JP2013039548A Pending JP2013129662A (ja) 2006-05-24 2013-02-28 デオキシノジリマイシンおよびd−アラビニトールのアナログおよび使用方法

Family Applications After (1)

Application Number Title Priority Date Filing Date
JP2013039548A Pending JP2013129662A (ja) 2006-05-24 2013-02-28 デオキシノジリマイシンおよびd−アラビニトールのアナログおよび使用方法

Country Status (8)

Country Link
US (1) US8975280B2 (https=)
EP (1) EP2023927B1 (https=)
JP (2) JP5241709B2 (https=)
CN (2) CN104876855A (https=)
CA (1) CA2652958C (https=)
ES (1) ES2537572T3 (https=)
HK (1) HK1214261A1 (https=)
WO (1) WO2007140184A2 (https=)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2009545621A (ja) * 2006-08-02 2009-12-24 ユナイテッド セラピューティクス コーポレーション ウィルス感染症のリポソーム処置
KR20100127842A (ko) * 2008-03-26 2010-12-06 유니버시티 오브 옥스퍼드 소포체 표적화 리포좀
EP2398321B1 (en) 2009-02-23 2015-11-25 United Therapeutics Corporation Iminosugars and methods of treating viral diseases
EP2400843B1 (en) * 2009-02-24 2015-11-11 United Therapeutics Corporation Iminosugars and methods of treating arenaviral infections
US8703744B2 (en) * 2009-03-27 2014-04-22 The Chancellor, Masters And Scholars Of The University Of Oxford Cholesterol level lowering liposomes
EP2411526A4 (en) * 2009-03-27 2012-09-19 Zacharon Pharmaceuticals Inc MODULATORS OF GANGLIOSID BIOSYNTHESIS
ES2524361T3 (es) * 2009-06-12 2014-12-05 United Therapeutics Corporation Iminoazúcares para su uso en el tratamiento de enfermedades por bunyavirus y togavirus
JP5653438B2 (ja) * 2009-09-04 2015-01-14 ユナイテッド セラピューティクス コーポレイション オルトミクソウイルス感染の治療方法
CA2772807A1 (en) * 2009-09-04 2011-03-10 The Chancellor, Masters And Scholars Of The University Of Oxford Methods of treating poxviral infections
CA2772813A1 (en) * 2009-09-04 2011-03-10 The Chancellor, Masters And Scholars Of The University Of Oxford Iminosugars and methods of treating filoviral diseases
KR20150035767A (ko) 2012-06-06 2015-04-07 유니터 바이롤로지, 엘엘씨 신규 이미노당 및 그의 용도
JP2016513729A (ja) * 2013-03-15 2016-05-16 ユニザー ヴィロロジー,エルエルシー 抗菌化合物
CN106102464A (zh) * 2013-05-02 2016-11-09 牛津大学之校长及学者 采用亚氨基糖的糖脂抑制
JP6456393B2 (ja) 2013-09-16 2019-01-23 エマージェント バイロロジー エルエルシー デオキシノジリマイシン誘導体およびその使用方法
BR112017008898B1 (pt) * 2014-11-05 2022-11-29 Emergent Virology Llc Compostos de iminoaçúcares, suas composições farmacêuticas e usos dos mesmos para tratar doenças virais
EP3318277A1 (en) 2016-11-04 2018-05-09 Institut du Cerveau et de la Moelle Epiniere-ICM Inhibitors of glucosylceramide synthase for the treatment of motor neuron diseases

Family Cites Families (30)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NO154918C (no) 1977-08-27 1987-01-14 Bayer Ag Analogifremgangsmaate til fremstilling av terapeutisk aktive derivater av 3,4,5-trihydroksypiperidin.
JPS54106477A (en) * 1978-02-03 1979-08-21 Nippon Shinyaku Co Ltd Moranoline derivative
JPS5943949B2 (ja) 1978-09-29 1984-10-25 日本新薬株式会社 モラノリンのn−置換誘導体
JPS5943948B2 (ja) * 1978-07-06 1984-10-25 日本新薬株式会社 置換モラノリン誘導体
JPS5943947B2 (ja) * 1978-05-03 1984-10-25 日本新薬株式会社 N−置換モラノリン誘導体
GB2020278B (en) * 1978-05-03 1983-02-23 Nippon Shinyaku Co Ltd Moranoline dervitives
DE3007078A1 (de) * 1980-02-26 1981-09-10 Bayer Ag, 5090 Leverkusen Neue derivate von 3,4,5-trihydroxypiperidin, verfahren zu ihrer herstellung und ihre verwendung als arzneimittel sowie in der tierernaehrung
DE3024901A1 (de) 1980-07-01 1982-01-28 Bayer Ag, 5090 Leverkusen Herbizide mittel auf basis von piperidin-derivaten
DE3620645A1 (de) * 1985-12-20 1987-07-02 Bayer Ag 3-amino-4,5-dihydroxypiperidine, verfahren zu ihrer herstellung und ihre verwendung
JPS62155291A (ja) 1985-12-20 1987-07-10 バイエル・アクチエンゲゼルシヤフト 3−アミノ−4,5−ジヒドロキシピペリジン類、それらの製造方法及びそれらの使用
DE3737523A1 (de) * 1987-11-05 1989-05-18 Bayer Ag Verwendung von substituierten hydroxypiperidinen als antivirale mittel
US4985445A (en) * 1988-02-12 1991-01-15 Meiji Seika Kaisha, Ltd. Cancer cell metastasis inhibitors and novel compounds
JPH0643306B2 (ja) * 1988-02-12 1994-06-08 明治製菓株式会社 癌細胞転移抑制剤
EP0350012A3 (en) * 1988-07-08 1990-09-05 Meiji Seika Kaisha Ltd. Antiviral composition
ES2086323T3 (es) * 1988-11-03 1996-07-01 Searle & Co Derivados del didesoxi-arabinitol como compuestos antiviricos.
JPH0675510B2 (ja) 1989-02-13 1994-09-28 日本新薬株式会社 モラノリン誘導体の製法
US5256788A (en) * 1989-02-13 1993-10-26 Nippon Shinyaku Co. Ltd. Moranoline derivatives and their production and the use of moranoline and its derivatives as a stabilizing agent for enzymes
US5051401A (en) * 1989-04-07 1991-09-24 University Of South Alabama Inhibition of mineral deposition by phosphorylated and related polyanionic peptides
DE4009561A1 (de) 1990-03-24 1991-09-26 Bayer Ag Neue desoxynojirimycinderivate, verfahren zu ihrer herstellung und ihre verwendung in arzneimitteln
CA2086413A1 (en) 1990-06-29 1991-12-30 Yohji Ezure Piperidine derivatives
US5290948A (en) 1990-09-17 1994-03-01 Mcneilab, Inc. Process for producing polyhydroxylated piperidines and pyrrolidines and compounds thereof
CA2181033C (en) 1994-01-13 2007-09-04 Timothy M. Block Use of n-alkyl derivatives of 1,5-dideoxy-1,5-imino-d-glucitol for the treatment of hepatitis b virus infections
AU1876095A (en) * 1994-02-25 1995-09-11 G.D. Searle & Co. Use of 1-deoxynojirimycin and its derivatives for treating mammals infected with respiratory syncytial virus
PT1030839E (pt) 1997-11-10 2004-05-31 Searle & Co Utilizacao de iminoacucares para tratar a resistencia a multifarmacos
DE69932154T2 (de) * 1998-02-12 2007-05-31 G.D. Searle Llc, Chicago Verwendung von n-substituirten-1,5-dideoxy-1,5-imino-d-glucitolen zur behandlung von hepatitis infektionen
GB0100889D0 (en) 2001-01-12 2001-02-21 Oxford Glycosciences Uk Ltd Compounds
JP2003522791A (ja) 2000-02-14 2003-07-29 ファルマシア コーポレイション 肝炎ウイルス感染症治療用n‐置換‐1,5‐ジデオキシ‐1,5‐イミノ‐d‐グルシトール化合物の使用
KR20050025144A (ko) * 2002-03-13 2005-03-11 데르 스포엘 아아르노우드 씨 반 수컷 피임에 대한 비호르몬적 접근법
US7994198B2 (en) * 2002-07-17 2011-08-09 Actelion Pharmaceuticals Ltd. Piperidinetriol derivatives as inhibitors of glycosylceramidsynthase
EP3782655A1 (en) * 2005-05-17 2021-02-24 Amicus Therapeutics, Inc. A method for the treatment of pompe disease using 1-deoxynojirimycin and derivatives

Similar Documents

Publication Publication Date Title
JP2009538336A5 (https=)
JP2006520339A5 (https=)
JP2010536766A5 (https=)
JP2004536811A5 (https=)
JP2007511546A5 (https=)
JP2013507423A5 (https=)
JP2007523139A5 (https=)
JP2010534247A5 (https=)
IN2006DE01793A (https=)
JP2012532135A5 (https=)
JP2012510502A5 (https=)
JP2006502283A5 (https=)
JP2010525122A5 (https=)
JP2011500769A5 (https=)
MY150047A (en) Method of producing 2'-deoxy-5-azacytidine (decitabine)
JP2005536519A5 (https=)
DE60326819D1 (de) Verfahren zur herstellung von inhibitoren der hmg-coa-reduktase
JP2009184932A5 (https=)
JP2008201774A5 (https=)
JP2012503653A5 (https=)
JP2009541414A5 (https=)
JP2005516898A5 (https=)
JP2006518765A5 (https=)
JP2004538278A5 (https=)
JP2009522364A5 (https=)